{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:52:34Z","timestamp":1788346354780,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wave Life Sciences"},{"name":"Wave Life Sciences"},{"name":"Wave Life Sciences"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtm.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T02:49:03Z","timestamp":1599792543000},"page":"162-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Investigational Assay for Haplotype Phasing of the Huntingtin Gene"],"prefix":"10.1016","volume":"19","author":[{"given":"Nenad","family":"Svrzikapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nripesh","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Boyanapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dorset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Yourstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Vargeese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.09.003_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0891988710383573","article-title":"The clinical and genetic features of Huntington disease","volume":"23","author":"Sturrock","year":"2010","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.omtm.2020.09.003_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.omtm.2020.09.003_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.09.003_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","article-title":"The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease","volume":"98","author":"Keum","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng0893-393","article-title":"Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease","volume":"4","author":"Snell","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib7","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2020.09.003_bib8","first-page":"65","article-title":"The biological function of the Huntingtin protein and its relevance to Huntington\u2019s disease pathology","volume":"5","author":"Schulte","year":"2011","journal-title":"Curr. Trends Neurol."},{"key":"10.1016\/j.omtm.2020.09.003_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtm.2020.09.003_bib10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2020.09.003_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","article-title":"Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion","volume":"17","author":"White","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib12","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/emboj.2008.133","article-title":"Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons","volume":"27","author":"Colin","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2020.09.003_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuron.2009.12.007","article-title":"Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin","volume":"65","author":"Twelvetrees","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2020.09.003_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/srep00140","article-title":"Huntingtin mediates dendritic transport of \u03b2-actin mRNA in rat neurons","volume":"1","author":"Ma","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.09.003_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","article-title":"Wild-type huntingtin protects neurons from excitotoxicity","volume":"96","author":"Leavitt","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtm.2020.09.003_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2020.09.003_bib17","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","article-title":"The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin","volume":"10","author":"Auerbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib18","doi-asserted-by":"crossref","first-page":"e1006846","DOI":"10.1371\/journal.pgen.1006846","article-title":"Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis","volume":"13","author":"Dietrich","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.09.003_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JHD-180290","article-title":"Cancer: from wild-type to mutant huntingtin","volume":"7","author":"Thion","year":"2018","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.omtm.2020.09.003_bib21","doi-asserted-by":"crossref","first-page":"djv208","DOI":"10.1093\/jnci\/djv208","article-title":"Unraveling the role of huntingtin in breast cancer metastasis","volume":"107","author":"Thion","year":"2015","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.omtm.2020.09.003_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2020.09.003_bib23","doi-asserted-by":"crossref","first-page":"e2101","DOI":"10.1212\/WNL.0000000000007147","article-title":"Clinical manifestations of homozygote allele carriers in Huntington disease","volume":"92","author":"Cubo","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2020.09.003_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2993","article-title":"Silencing disease genes in the laboratory and the clinic","volume":"226","author":"Watts","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.omtm.2020.09.003_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cge.12385","article-title":"Personalized gene silencing therapeutics for Huntington disease","volume":"86","author":"Kay","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington\u2019s disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtm.2020.09.003_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3948","article-title":"Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides","volume":"35","author":"Iwamoto","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2020.09.003_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington\u2019s disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omtm.2020.09.003_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fgene.2019.00426","article-title":"Long-read sequencing emerging in medical genetics","volume":"10","author":"Mantere","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ejhg.2017.125","article-title":"Haplotype-based stratification of Huntington\u2019s disease","volume":"25","author":"Chao","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/mt.2015.128","article-title":"Huntingtin haplotypes provide prioritized target panels for allele-specific silencing in Huntington disease patients of European ancestry","volume":"23","author":"Kay","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.003_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","article-title":"Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region","volume":"90","author":"Lee","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","article-title":"CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup","volume":"84","author":"Warby","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib35","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/gepi.20533","article-title":"MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes","volume":"34","author":"Li","year":"2010","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.omtm.2020.09.003_bib36","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1038\/s41467-019-13225-y","article-title":"Accurate, scalable and integrative haplotype estimation","volume":"10","author":"Delaneau","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.09.003_bib37","article-title":"WhatsHap: fast and accurate read-based phasing","author":"Martin","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2020.09.003_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gpb.2015.08.002","article-title":"PacBiol. sequencing and its applications","volume":"13","author":"Rhoads","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.omtm.2020.09.003_bib39","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/gim.2014.146","article-title":"American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease","volume":"16","author":"Bean","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.09.003_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington\u2019s disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2020.09.003_bib41","doi-asserted-by":"crossref","first-page":"giz122","DOI":"10.1093\/gigascience\/giz122","article-title":"A high-quality genome assembly from a single, field-collected spotted lanternfly (Lycorma delicatula) using the PacBio Sequel II system","volume":"8","author":"Kingan","year":"2019","journal-title":"Gigascience"},{"key":"10.1016\/j.omtm.2020.09.003_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1101\/gr.112730.110","article-title":"Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons","volume":"21","author":"Haas","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.09.003_bib43","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1073\/pnas.93.7.2969","article-title":"Formation of chimeric DNA primer extension products by template switching onto an annealed downstream oligonucleotide","volume":"93","author":"Patel","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.09.003_bib44","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1212\/NXG.0000000000000430","article-title":"Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease","volume":"6","author":"Claassen","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ejhg.2011.136","article-title":"Discrepancies in reporting the CAG repeat lengths for Huntington\u2019s disease","volume":"20","author":"Quarrell","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.003_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1214\/aoms\/1177697203","article-title":"The weighted likelihood ratio, sharp hypothesis about chances, the order of a Markov chain","volume":"41","author":"Dickey","year":"1970","journal-title":"Ann. Math. Stat."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:12Z","timestamp":1762421112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"alternative-id":["S2329050120301881"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.09.003","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigational Assay for Haplotype Phasing of the Huntingtin Gene","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}